Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
about
Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010.Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal studyCannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cellsModulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.Cannabinoids and Viral Infections.Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.Effects of marijuana smoking on the lung.Cannabis smoking and respiratory health: consideration of the literature.Clinical applications of hallucinogens: A review.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsCB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesiclesExposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes.Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.Serum and gene expression profile of cytokines in first-episode psychosis.Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion modelCannabinoids, endocannabinoids, and related analogs in inflammationBiological networks in ischemic tolerance - rethinking the approach to clinical conditioningThe cannabinoid receptor 2 is critical for the host response to sepsis.Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Cannabis, the pregnant woman and her child: weeding out the myths.Novel approaches to the development of anti-sepsis drugs.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Effects of cannabinoids and their receptors on viral infections.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation.
P2860
Q27312420-11515A50-5E07-4477-8E7B-1E832FF7863AQ28395270-4F4A05F0-192C-4E59-B205-CB53621F3649Q33581824-87F39F88-4915-45FC-A256-12890C709353Q33793559-1D890BE9-B314-4820-979E-AC5378143CE7Q33992923-825F33A3-BDCD-4CB4-8698-1B3CA67048BFQ34339177-0C07F50C-0D46-49E1-9F69-D6B4AD804172Q34353689-B0B876FB-DAD5-4533-8B5B-E0CAC5EC5DACQ34420153-B242B49E-DEB0-4866-B4AF-B026FBA26352Q34535259-290E34EF-1D5D-48CC-849A-0CEEA46DC874Q34700334-7C3EC01F-1FE8-4DB2-8841-7586F8EB5B27Q35023230-F015DD17-5686-42E2-8B6A-A6830F5EC2D1Q35748304-8269D8B8-243D-4049-8E8A-86548D09F101Q35752103-920AACA5-6168-4FE7-AE93-A006D5CC5DA9Q35766665-5142158D-FBEC-4AC6-9CCD-CC474E48DE71Q35784024-D3EB4003-A133-40DC-BC9C-AFB647A31AACQ35870490-7655230D-804C-447F-B1D2-9E277F9E8F12Q36166294-7831905C-B639-403D-AABE-A1E3A993111DQ36176444-A357A7BA-AA39-430C-93E6-55B2EE1E74F3Q36398092-B3135748-63FB-4D04-8FD7-698218C84FBAQ36653071-38DEB607-4EEA-4E3D-9A9F-BB611B057558Q36711079-F5245E1F-AD45-4D53-8D92-7F35D440C434Q36910378-A672CD66-DD29-41E9-B107-9544ED116CA2Q36938493-F0BF7281-B2D5-4476-B3EB-7F823A229ABEQ36961126-04A97378-3335-4190-8D97-3E2A0BCE87D7Q37087780-329C7B9B-E625-4393-931C-37A1F99D123DQ37149113-0C50C479-7B6F-4B22-9986-FF06DC624657Q37291743-8D109591-022E-4E94-9E62-96F8DEC3E0D6Q37390259-0701A69A-8638-4D2C-A0EB-87D5019C5C64Q37396781-A337A716-551D-4F83-97B9-39609A0FF567Q37490376-1D2C7758-27FB-4824-B2C0-E16A5EF34DC0Q37801335-081C4835-6C28-4A2C-A6FA-127E7BEFE1ABQ37919370-F38A225C-CFA3-4129-B50A-2687713DD736Q38072364-A7873EEE-7CA5-4A9C-A8C0-9A053B9DEF0AQ38181303-644AEB42-8550-4C59-B805-D497E2A1641CQ38201746-23D13B38-E52C-4498-8D17-7DED0FB15ECBQ38220272-783B28DB-1D16-4EA6-91D7-A8CCABEDD298Q38503842-14C5EAE2-E3DE-4C66-A258-BECDAF8840D5Q38522557-AED286B8-A0CA-4A6D-8E05-7593EE4E1588Q38600704-D5CF41CB-F66F-4537-AEB0-4A3C36AE9595Q38709451-28A02D6E-907D-40AC-BA00-4EF4F5A8ED92
P2860
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@en
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@nl
type
label
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@en
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@nl
prefLabel
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@en
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@nl
P2860
P1476
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
@en
P2093
Guy A Cabral
Thomas W Klein
P2860
P2888
P356
10.1007/S11481-005-9007-X
P577
2006-03-01T00:00:00Z